BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $67,342,917 | +112.6% | 1,784,391 | +156.7% | 0.14% | +95.7% |
| Q2 2023 | $31,671,125 | -33.0% | 695,152 | -40.4% | 0.07% | -41.2% |
| Q1 2023 | $47,305,533 | +238.9% | 1,166,310 | +325.9% | 0.12% | +213.2% |
| Q4 2022 | $13,957,013 | -91.0% | 273,828 | -90.5% | 0.04% | -92.0% |
| Q3 2022 | $154,532,000 | +607.6% | 2,869,138 | +743.9% | 0.47% | +567.6% |
| Q2 2022 | $21,838,000 | -50.7% | 340,000 | -38.3% | 0.07% | -61.4% |
| Q3 2021 | $44,294,000 | +18128.0% | 550,721 | +19373.9% | 0.18% | +9100.0% |
| Q2 2020 | $243,000 | -99.4% | 2,828 | -99.4% | 0.00% | -99.6% |
| Q1 2020 | $38,695,000 | +68.3% | 476,603 | +73.3% | 0.46% | +237.5% |
| Q4 2019 | $22,996,000 | -76.8% | 275,000 | -77.3% | 0.14% | -78.5% |
| Q2 2019 | $99,096,000 | +558.4% | 1,209,969 | +553.6% | 0.63% | +533.0% |
| Q1 2019 | $15,052,000 | -64.4% | 185,117 | -71.2% | 0.10% | -67.2% |
| Q4 2018 | $42,333,000 | +1044.8% | 643,161 | +1240.6% | 0.30% | +1694.1% |
| Q3 2018 | $3,698,000 | -65.5% | 47,975 | -66.9% | 0.02% | -65.3% |
| Q2 2018 | $10,717,000 | -62.3% | 145,149 | -66.8% | 0.05% | -58.8% |
| Q1 2018 | $28,434,000 | +46.1% | 437,171 | +45.2% | 0.12% | +95.1% |
| Q4 2017 | $19,461,000 | +83.7% | 301,071 | +78.3% | 0.06% | +45.2% |
| Q3 2017 | $10,596,000 | +10.0% | 168,865 | +6.1% | 0.04% | +5.0% |
| Q2 2017 | $9,636,000 | -60.4% | 159,175 | -66.1% | 0.04% | -64.9% |
| Q1 2017 | $24,341,000 | +61.4% | 469,355 | +38.0% | 0.11% | +40.7% |
| Q4 2016 | $15,077,000 | -62.2% | 340,023 | -65.0% | 0.08% | -65.8% |
| Q1 2016 | $39,895,000 | -59.7% | 971,147 | -62.5% | 0.24% | -65.5% |
| Q4 2015 | $98,884,000 | +2.1% | 2,591,966 | -12.1% | 0.69% | -4.1% |
| Q3 2015 | $96,881,000 | +45.6% | 2,949,179 | +210.0% | 0.72% | +74.8% |
| Q2 2015 | $66,537,000 | +320.9% | 951,477 | +312.3% | 0.41% | +219.5% |
| Q1 2015 | $15,807,000 | -14.5% | 230,761 | -10.5% | 0.13% | -10.5% |
| Q3 2014 | $18,496,000 | +31.8% | 257,715 | +35.1% | 0.14% | -10.1% |
| Q1 2014 | $14,036,000 | -45.8% | 190,761 | -48.8% | 0.16% | -52.8% |
| Q4 2013 | $25,903,000 | +205.7% | 372,436 | +188.7% | 0.34% | +195.6% |
| Q3 2013 | $8,474,000 | -36.4% | 129,000 | -32.9% | 0.11% | -49.1% |
| Q2 2013 | $13,322,000 | – | 192,313 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |